VEGFA and metastatic carcinoma: The humanized VEGF antibody, known as AvastinTM or bevacizumab, has been approved by the FDA for treating metastatic carcinoma of the colon or rectum [106] and recurrent or metastatic non-squamous non-small cell lung cancer [107].